Biopharma Partner Services
FoundationOne Liquid CDx
FoundationOne®Liquid CDx, the broadest FDA-approved liquid biopsy, is now the only blood-based comprehensive genomic profiling companion diagnostic (CDx) for Lynparza® (olaparib) in prostate cancer.
Biopharma Partner FAQ
Foundation Medicine at #ASCO21
We’re excited to share our work in advancing precision medicine in oncology at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting. Learn more.